Table 3.
Distribution infection of gynaecological outpatients with 21 subtypes of human papillomavirus (HPV) in different years.
| Positive case | 2012 (n=22) | 2013 (n=24) | 2014 (n=20) | 2015 (n=30) | 2016 (n=26) | χ2 | p | Linear-by-linear association | p | Gamma value | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| HPV6 | 38 | 6 (27.3%) | 7 (29.2%) | 8 (40.0%) | 12 (40.0%) | 5 (19.2%) | 3.747 | .441 | .035 | .852 | −.038 |
| HPV 11 | 32 | 9 (40.9%) | 7 (29.2%) | 4 (20.0%) | 10 (33.3%) | 2 (7.7%) | 8.358 | .079 | 4.515 | .034* | −.311 |
| HPV 16 | 23 | 9 (40.9%) | 4 (16.7%) | 2 (10.0%) | 2 (6.7%) | 6 (23.1%) | 11.311 | .023* | 3.003 | .083 | −.257 |
| HPV 18 | 16 | 2 (9.1%) | 1 (4.2%) | 2 (10.0%) | 5 (16.7%) | 6 (23.1%) | 4.766 | .312 | 3.679 | 0.055 | .371 |
| HPV 31 | 6 | 1 (4.5%) | 1 (4.2%) | 1 (5.0%) | 2 (6.7%) | 1 (3.8%) | .296 | .990 | .008 | .927 | .022 |
| HPV 35 | 9 | 1 (4.5%) | 2 (8.3%) | 1 (5.0%) | 1 (3.3%) | 4 (15.4%) | 3.614 | .461 | .935 | .334 | .252 |
| HPV 39 | 7 | 0 (0.0%) | 1 (4.2%) | 1 (5.0%) | 2 (6.7%) | 3 (11.5%) | 3.134 | .536 | 2.881 | .090 | .476 |
| HPV 42 | 11 | 4 (18.2%) | 2 (8.3%) | 2 (10.0%) | 2 (6.7%) | 1 (3.8%) | 3.339 | .503 | 2.609 | .106 | −.356 |
| HPV43 | 6 | 1 (4.5%) | 0 (0.0%) | 2 (10.0%) | 2 (6.7%) | 1 (3.8%) | 2.613 | .625 | .149 | .699 | .100 |
| HPV 45 | 7 | 1 (4.5%) | 2 (8.3%) | 1 (5.0%) | 1 (3.3%) | 2 (7.7%) | .881 | .927 | .003 | .957 | .022 |
| HPV 52 | 13 | 1 (4.5%) | 3 (12.5%) | 2 (10.0%) | 4 (13.3%) | 3 (11.5%) | 1.205 | .877 | .525 | .469 | .148 |
| HPV 53 | 14 | 2 (9.1%) | 4 (16.7%) | 0 (0.0%) | 3 (10.0%) | 5 (19.2%) | 4.956 | .292 | .460 | .498 | .153 |
| HPV 56 | 9 | 1 (4.5%) | 3 (12.5%) | 3 (15.0%) | 0 (0.0%) | 2 (7.7%) | 5.274 | .260 | .245 | .620 | −.120 |
| HPV 58 | 6 | 1 (4.5%) | 0 (0.0%) | 2 (10.0%) | 1 (3.3%) | 2 (7.7%) | 2.942 | .568 | .464 | .496 | .199 |
| HPV 59 | 10 | 2 (9.1%) | 1 (4.2%) | 1 (5.0%) | 3 (10.0%) | 3 (11.5%) | 1.328 | .857 | .439 | .508 | .162 |
| HPV 66 | 8 | 4 (18.2%) | 1 (4.2%) | 1 (5.0%) | 1 (3.3%) | 1 (3.8%) | 5.976 | .201 | 3.170 | .075 | −.441 |
| HPV 68 | 7 | 2 (9.1%) | 1 (4.2%) | 1 (5.0%) | 3 (10.0%) | 0 (0.0%) | 3.177 | .529 | .590 | .443 | −.224 |
| HPV 82 | 8 | 3 (13.6%) | 0 (0.0%) | 2 (10.0%) | 3 (10.0%) | 0 (0.0%) | 6.275 | .180 | 1.017 | .313 | −.271 |
| HPV 73 | 4 | 1 (4.5%) | 1 (4.2%) | 1 (5.0%) | 1 (3.3%) | 0 (0.0%) | 1.240 | .872 | .774 | .379 | −.326 |
| HPV 33 | 4 | 1 (4.5%) | 0 (0.0%) | 1 (5.0%) | 1 (3.3%) | 1 (3.8%) | 1.138 | .888 | .037 | .847 | .069 |
| HPV 51 | 15 | 3 (13.6%) | 4 (16.7%) | 2 (10.0%) | 3 (10.0%) | 2 (7.7%) | 1.211 | .876 | .848 | .357 | −.185 |
Linear-by -linear Association test and Gamma Value for trend to evaluate changes in HPV prevalence by calendar year group.
*
p<0.05.